BioMérieux New Products Posted to GenomeWeb: Bio-Rad, BD, Analytik Jena, BioMérieux New products and services posted to GenomeWeb for the week of Jan. 30, 2023. In Brief This Week: SD Biosensors, Meridian, Oncocyte, Opko Health, GeneDx, More News items for the week of Jan. 30, 2023. In Brief This Week: Meridian Bioscience, BioMérieux, Applied DNA Sciences, More News items for the week of Dec. 12, 2022. BioMérieux Q3 Revenues up 3 Percent The Marcy l’Étoile, France-based firm said sales of its non-respiratory syndromic molecular panels increased 30 percent in the quarter. BioMérieux Gets Health Canada Approval for Updated BioFire Blood Culture ID Panel The panel includes additional pathogen targets and resistance genes, as well as revised targets compared to the original BCID panel. May 20, 2022 In Brief This Week: Thermo Fisher Scientific, Bruker, Quantum-Si, BioMérieux, More May 4, 2022 BioMérieux Joint Infection Panel Gets FDA De Novo Authorization Apr 11, 2022 BioMérieux Posts 1 Percent Drop in Q1 Revenues Apr 7, 2022 MALDI Clinical Microbiology Releases Bring New Features, Could Open Additional US Markets Premium Mar 18, 2022 BioMérieux Gets FDA 510(k) Clearance for MALDI-TOF Bacterial ID System Mar 2, 2022 BioMérieux Reports 8 Percent Revenue Growth in Q4 Jan 28, 2022 Streck Gets FDA Clearance for BioFire Sepsis Panel Control Material Sep 1, 2021 BioMérieux H1 Revenues Rise 7 Percent Aug 31, 2021 Startup BioFlyte Detects Airborne SARS-CoV-2 Using BioFire FilmArray Premium May 7, 2021 BioMérieux Receives CE Mark for Vitek Clinical Microbiology Mass Spec System Apr 27, 2021 BioMérieux Reports 10 Percent Q1 Revenue Growth, Lowers Full-Year Guidance Mar 18, 2021 BioFire Dx Receives First FDA Marketing Clearance for SARS-CoV-2 Respiratory Panel Feb 24, 2021 BioMérieux Reports 21 Percent Revenue Growth in Q4 Dec 23, 2020 In Brief This Week: Natera, Sync for Genes, Castle Biosciences, BioMérieux, PathogenDx, More Dec 16, 2020 BioMérieux Nabs CE Mark for RT-PCR SARS-CoV-2, Influenza A/B Assay Dec 8, 2020 BioMérieux Coronavirus Test Gets FDA OK for Use With Pooled Samples Oct 22, 2020 BioMérieux Q3 Revenues Increase 21 Percent Sep 8, 2020 As Flu Season Nears, Dx Companies Shift Attention to Multiplex Tests for SARS-CoV-2, Influenza Premium Sep 2, 2020 BioMérieux Posts 16 Percent Sales Growth for First Half of 2020 Jul 21, 2020 AdvaMed Partners With Dx Companies to Create National COVID-19 Supply Registry Load More Breaking News Bio-Rad Laboratories, Cytek Biosciences Partner on Flow Cytometry Reagents Tecan Inks Deals for NGS Library Prep System With Element Biosciences, Singular Genomics Genomenon, Flagship Biosciences Partner on Biomarker Discovery, Companion Dx Development Velsera to Integrate Arima Genomics Gene Fusion Test in Pierian Clinical Platform Evonetix Raises $24M in Extended Series B Funding Round The Scan Study Points to Tuberculosis Protection by Gaucher Disease Mutation A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds. SpliceVault Portal Provides Look at RNA Splicing Changes Linked to Genetic Variants The portal, described in Nature Genetics, houses variant-related messenger RNA splicing insights drawn from RNA sequencing data in nearly 335,700 samples — a set known as the 300K-RNA resource. Automated Sequencing Pipeline Appears to Allow Rapid SARS-CoV-2 Lineage Detection in Nevada Study Researchers in the Journal of Molecular Diagnostics describe and assess a Clear Labs Dx automated workflow, sequencing, and bioinformatic analysis method for quickly identifying SARS-CoV-2 lineages. UK Team Presents Genetic, Epigenetic Sequencing Method Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.